Actively Recruiting

Age: 18Years - 64Years
All Genders
ID05549102

The Impact of CBT on Shock-Potentiated Neural Circuity

Led by UCLH/UCL Joint Research Office · Updated on 2025-06-29

174

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

UCLH/UCL Joint Research Office

Lead Sponsor

M

Medical Research Council

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying how cognitive behavioral therapy (CBT) affects the brain circuits involved in anxiety disorders. This study aims to understand the neurobiological mechanisms behind CBT's effects, focusing on the amygdala and prefrontal cortex. The goal is to develop better targeted treatments for anxiety by identifying how CBT changes brain function compared to waiting list controls. This study also compares these effects to pharmacological treatments for anxiety. Participants are divided into two groups: those receiving a course of CBT and those on a waiting list for CBT. The CBT group will receive 12-15 weekly therapy sessions following national guidelines, where they discuss and work on patterns of thinking and behavior. Both groups will be tested before and after the treatment or waiting period, up to 12 weeks, using brain imaging and cognitive tasks. During the study, participants will complete computer-based emotional and cognitive tasks and undergo brain scans using functional MRI. Various psychological questionnaires will assess anxiety, depression, stress, and related behaviors. Researchers will monitor brain connectivity changes and cognitive performance to understand how CBT influences anxiety. The total study duration includes assessments at the start and after the treatment or waiting period, with data compared between groups.

CONDITIONS

Brief Title

CBT and the Neural Circuits of Anxiety

Who Can Participate

Age: 18Years - 64Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Enrolled in IAPT Step 3 (high intensity service)
  • Score of or above 8 on the GAD-7 (indicating moderate anxiety)
  • Willing and able to provide written consent
  • Aged between 18 and 64 years
Not Eligible

You will not qualify if you...

  • Score above 22 on the GAD-7
  • Past or present psychotic disorder, bipolar disorder/mania, or alcohol/substance use disorder (outside a comorbid episode)
  • History of medical illness impairing cognitive function (e.g., serious head injury, endocrine disorder)
  • Current or recent (within 3 months) psychotropic medication use (e.g., SSRIs)
  • MRI contraindications such as pacemaker, aneurysm clip, cochlear implant, neurostimulator, IUD, shrapnel, metal fragments in eye, weight over 250 lbs, or claustrophobia
  • Females who are pregnant, planning pregnancy, or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for clinical and questionnaire assessments

Outpatient Treatment

Duration - 12 to 15 weeks

Participants undergoing a course of Cognitive Behavioural Therapy (CBT) will receive weekly therapy sessions as part of their routine care in the IAPT programme. CBT involves discussions to identify and change problematic thinking and behaviour patterns to improve mental health.

Weekly therapy sessions for 12 to 15 weeks

Monitoring

Duration - Up to 12 weeks after treatment or waiting period

Participants are assessed before and after the treatment or waiting period using cognitive and neuroimaging tests to measure brain function and emotional processing related to anxiety.

2 visits (one before and one after treatment or waiting period) involving computerised cognitive tasks and fMRI scanning

Trial Site Locations

Total: 1 location

1

Institute of Cognitive Neuroscience, University College London

London, United Kingdom, WC1N 3AZ

Actively Recruiting

Loading map...

Research Team

E

Emily Lewis

O

Oliver Robinson

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Erectile Function After Percutaneous Coronary Intervention i...

Erectile Disfunction

Actively Recruiting

1 location

Machine Learning Analysis of Lingual Colorimetry and MADRS S...

Anxiety Disorders

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here